Measurement of serum cystatin C in patients with epilepsy

Fengying Liu,Xuekun Cai,Minling Tan,Zhiqiang Xu
DOI: https://doi.org/10.3969/j.issn.1673-5110.2013.02.001
2013-01-01
Abstract:Objective To explore the role of cystatin C(Cys C) in patients with various types of seizure and various kinds of epilepsy in pathogeny.Methods The serum levels of Cys C was determined by latex enhanced immunoturbidimetry assay in 95 epilepsy patients as trial group and 95 healthy as normal control group.Results The serum Cys C concentrations in trial group[(1.26±0.68)mg/L]was significantly higher compared to that in normal control group[(0.84±0.13)mg/L](F=28.84,P<0.01).However,there was no significant difference in Cys C between men and women in each group(P>0.05).In trial group,there was no significant difference in Cys C between every two groups among the three groups according to the pathogeny of epilepsy and the types of seizure(P>0.05).Conclusion The ascendant Cys C may be the hopeful biomarker in the diagnosis of epilepsy.It is suggested that it will be helpful to research new drugs for the treatment of epilepsy patients.
What problem does this paper attempt to address?